WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Stock Ownership - Who owns Compass Therapeutics?

Insider buying vs selling

Have Compass Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vered BiskerleibCHIEF EXECUTIVE OFFICER2024-02-0849,198$1.45
$71.34kSell
Thomas J. SchuetzPRESIDENT2024-02-0844,782$1.45
$64.93kSell
Vered BiskerleibChief Executive Officer2024-01-091,753,125$1.93
$3.38MBuy
Thomas J. SchuetzPresident of RD2024-01-09637,500$1.93
$1.23MBuy
Vered BiskerleibChief Operating Officer2023-11-1764,415$1.50
$96.62kSell
Thomas J. SchuetzCHIEF EXECUTIVE OFFICER2023-11-1744,025$1.50
$66.04kSell

1 of 1

CMPX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CMPX insiders and whales buy or sell their stock.

CMPX Shareholders

What type of owners hold Compass Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC16.25%22,362,850$44.28MInstitution
Adage Capital Partners GP LLC7.18%9,880,000$19.56MInstitution
Thomas J. Schuetz4.78%6,570,566$13.01MInsider
Janus Henderson Group PLC4.76%6,547,231$12.96MInstitution
Blackrock Inc4.52%6,222,309$12.32MInstitution
Blackstone Inc4.50%6,189,551$12.26MInstitution
Rock Springs Capital Management LP4.01%5,513,788$10.92MInstitution
Fmr LLC3.31%4,551,506$9.01MInstitution
Vanguard Group Inc2.97%4,081,189$8.08MInstitution
Carl L. Gordon2.60%3,571,428$7.07MInsider

1 of 3

CMPX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMPX62.59%12.24%Net BuyingNet Buying
IMMP0.17%0.00%
XERS42.66%15.51%Net BuyingNet Buying
IPSC27.27%59.24%Net SellingNet Selling
CDXC8.22%91.78%Net Buying

Compass Therapeutics Stock Ownership FAQ

Who owns Compass Therapeutics?

Compass Therapeutics (NASDAQ: CMPX) is owned by 62.59% institutional shareholders, 12.24% Compass Therapeutics insiders, and 25.18% retail investors. Thomas J. Schuetz is the largest individual Compass Therapeutics shareholder, owning 6.57M shares representing 4.78% of the company. Thomas J. Schuetz's Compass Therapeutics shares are currently valued at $13.47M.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.